87736-74-1

Basic information

• Product Name: 4-TBDMS-HYDROXYMETHYLBROMOBENZENE
• Synonyms: 4-TBDMS-HYDROXYMETHYLBROMOBENZENE;1-Bromo-4-[[(tert-butyldimethylsilyl)oxy]methyl]benzene;(4-BroMobenzyl)oxy](tert-butyl)diMethylsilane;1-BroMo-4-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]-benzene;4-(tert-ButyldiMethylsilyloxyMethyl)broMobenzene;4-BroMobenzyl diMethyl-tert-butylsilyl Ether;Benzene, 1-broMo-4-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]-;[(4-Bromobenzyl)oxy](tert-butyl)dimethylsilane
• CAS NO: 87736-74-1
• Molecular Formula: C₁₃H₂₁BrOSi
• Molecular Weight: 301.29
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 87736-74-1.mol
• Article Data: 52

Chemical Properties

• Boiling Point: 338.833°C at 760 mmHg
• Flash Point: 158.721°C
• Appearance: /
• Density: 1.145
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.527
• Storage Temp.: 2-8°C
• Solubility: Dichloromethane, Diethyl Ether, Methanol
• CAS DataBase Reference: 4-TBDMS-HYDROXYMETHYLBROMOBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-TBDMS-HYDROXYMETHYLBROMOBENZENE(87736-74-1)
• EPA Substance Registry System: 4-TBDMS-HYDROXYMETHYLBROMOBENZENE(87736-74-1)

Safety Data

• Hazardous Substances Data: 87736-74-1(Hazardous Substances Data)

Usage

Chemical Properties

Colorless Oil

Uses

(4-bromophenyl)methoxy-tert-butyl-dimethylsilane is used in the preparation of aromatic bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.

InChI:InChI=1/C13H21BrOSi/c1-13(2,3)16(4,5)11-6-7-12(14)10(8-11)9-15/h6-8,15H,9H2,1-5H3

Upstream product

• 873-75-6 4-bromobenzenemethanol 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 288-32-4 1H-imidazole 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 108-48-5 2,6-dimethylpyridine 
• 7732-18-5 water 
• 75-05-8 acetonitrile 
• 156185-88-5 3-amino-2(S)-phenylsulfonylaminopropionic acid 

Downstream Products

• 807616-80-4 (RS)-1-[4'-(tert-butyldimethylsilyloxymethyl)phenyl]cyclohex-2-en-1-ol 
• 630407-57-7 7-[4-(tert-butyidimethylsilyloxymethyl)benzenesulfonyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline 
• 81443-46-1 2-(4-Bromomethylphenyl)thiophene 
• 108912-09-0 3-(4-bromomethyl-phenyl)thiophene 
• 849146-84-5 N-(1-naphthyl)-N,N'-diphenyl-N'-(4-((4-vinylphenyl)methoxymethyl)phenyl)benzidine 
• 849146-82-3 N,N,N'-triphenyl-N'-(4-((4-vinylphenyl)methoxymethyl)phenyl)benzidine 
• 849146-80-1 N-(1-naphthyl)-N,N'-diphenyl-N'-(4-(hydroxymethyl)phenyl)benzidine 
• 849146-81-2 N,N,N'-triphenyl-N'-(4-((4-vinylphenyl)methoxymethyl)phenyl)-p-phenylenediamine 
• 849146-78-7 N,N,N'-triphenyl-N'-(4-(hydroxymethyl)phenyl)benzidine 
• 849146-77-6 N,N,N'-triphenyl-N'-(4-(hydroxymethyl)phenyl)-p-phenylenediamine 
• 865761-88-2 diethyl[4-(3,7-dimethylocta-2,6-dienyl)benzyl]phosphonate 
• 865761-87-1 1-(3,7-dimethylocta-2,6-dienyl)-4-iodomethylbenzene 
• 865761-86-0 [4-(3,7-dimethylocta-2,6-dienyl)phenyl]methanol 

Relevant articles and documents

Charge-tagged polar phosphine ligands in Pd-catalysed reactions in aqueous and ionic media

A new range of polar imidazolium and phosphate-containing ligands was synthesised from readily available starting materials in high yielding multi-step transformations. These ligands were used to generate Pd catalysts for Suzuki and Heck C–C coupling reac

Iron-Catalyzed Ring Expansion of Cyclobutanols for the Synthesis of 1-Pyrrolines by Using MsONH3OTf

The synthesis of 1-pyrrolines from cyclobutanol derivatives and an aminating reagent (MsONH3OTf) has been developed. This one-pot procedure achieves C–N bond/C═N bond formation via ring expansion. A series of 1-pyrroline derivatives are synthes

Preparation method 4 - hydroxymethylphenylboronic acid

The invention relates to the technical field of organic synthesis. The invention specifically discloses a preparation method of 4 -hydroxymethylphenylboronic acid. To the preparation method, bromobenzyl alcohol is taken as a raw material, Grignard reagent

SILICON-FLUORIDE ACCEPTOR SUBSTITUTED RADIOPHARMACEUTICALS AND PRECURSORS THEREOF

A ligand-SiFA conjugate compound represented by formula (1) wherein: RL is a ligand moiety which is capable of binding to prostate-specific membrane antigen (PSMA); RSiFA is a silicon-fluoride acceptor (SiFA) moiety which can be labe